BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹31 Cr | ₹20 Cr | ₹23 Cr | ₹-1.54 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹-1.54 Cr |
| Mar2022 | ₹27 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 51.78 | |
| Mar2025 | ₹20 Cr | -10.92 | |
| Mar2024 | ₹23 Cr | Positive | |
| Mar2023 | ₹-1.54 Cr | Negative | |
| Mar2022 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹136.1 Cr | 2.6% | -11.8% | 10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 2.6% |
-11.8% |
10% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses